CRI_JBF_082714_62912
-
Upload
priyaranjan -
Category
Documents
-
view
220 -
download
4
description
Transcript of CRI_JBF_082714_62912
CRISIL IER Independent Equity Research
Enhancing investment decisions
JBF Industries Ltd
Q1FY15 Results Update
CRISIL IER Independent Equity Research
Explanation of CRISIL Fundamental and Valuation (CFV) matrix
The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis of an investment making process – Analysis
of Fundamentals (addressed through Fundamental Grade) and Analysis of Returns (Valuation Grade) The fundamental grade is assigned on a
five-point scale from grade 5 (indicating Excellent fundamentals) to grade 1 (Poor fundamentals) The valuation grade is assigned on a five-
point scale from grade 5 (indicating strong upside from the current market price (CMP)) to grade 1 (strong downside from the CMP).
CRISIL
Fundamental Grade Assessment
CRISIL
Valuation Grade Assessment
5/5 Excellent fundamentals 5/5 Strong upside (>25% from CMP)
4/5 Superior fundamentals 4/5 Upside (10-25% from CMP)
3/5 Good fundamentals 3/5 Align (+-10% from CMP)
2/5 Moderate fundamentals 2/5 Downside (negative 10-25% from CMP)
1/5 Poor fundamentals 1/5 Strong downside (<-25% from CMP)
About CRISIL Limited
CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India’s leading ratings agency.
We are also the foremost provider of high-end research to the world’s largest banks and leading corporations.
About CRISIL Research
CRISIL Research is India's largest independent and integrated research house. We provide insights, opinions, and analysis on the Indian
economy, industries, capital markets and companies. We are India's most credible provider of economy and industry research. Our industry
research covers 70 sectors and is known for its rich insights and perspectives. Our analysis is supported by inputs from our network of more
than 4,500 primary sources, including industry experts, industry associations, and trade channels. We play a key role in India's fixed income
markets. We are India's largest provider of valuations of fixed income securities, serving the mutual fund, insurance, and banking industries.
We are the sole provider of debt and hybrid indices to India's mutual fund and life insurance industries. We pioneered independent equity
research in India, and are today India's largest independent equity research house. Our defining trait is the ability to convert information and
data into expert judgements and forecasts with complete objectivity. We leverage our deep understanding of the macroeconomy and our
extensive sector coverage to provide unique insights on micro-macro and cross-sectoral linkages. We deliver our research through an
innovative web-based research platform. Our talent pool comprises economists, sector experts, company analysts, and information
management specialists.
CRISIL Privacy
CRISIL respects your privacy. We use your contact information, such as your name, address, and email id, to fulf il your request and service
your account and to provide you with additional information from CRISIL and other parts of McGraw Hill Financial you may find of interest.
For further information, or to let us know your preferences with respect to receiving marketing materials, please visit www.crisil.com/privacy.
You can view McGraw Hill Financial’s Customer Privacy Policy at http://www.mhfi.com/privacy.
Last updated: May, 2013
Analyst Disclosure
Each member of the team involved in the preparation of the grading report, hereby affirms that there exists no conflict of interest that can bias
the grading recommendation of the company.
Disclaimer:
This Company commissioned CRISIL IER report is based on data publicly available or from sources considered reliable. CRISIL Ltd.
(CRISIL) does not represent that it is accurate or complete and hence, it should not be relied upon as such. The data / report is subject to
change without any prior notice. Opinions expressed herein are our current opinions as on the date of this report. Nothing in this report
constitutes investment, legal, accounting or tax advice or any solicitation, whatsoever. The subscriber / user assume the entire risk of any use
made of this data / report. CRISIL especially states that, it has no financial liability whatsoever, to the subscribers / users of this report. This
report is for the personal information only of the authorised recipient in India only. This report should not be reproduced or redistributed or
communicated directly or indirectly in any form to any other person – especially outside India or published or copied in whole or in part, for any
purpose.
JBF Industries Ltd
Improvement in EBITDA margin may be temporary
Fundamental Grade 2/5 (Moderate fundamentals)
Valuation Grade 2/5 (CMP has downside)
Industry Chemicals
1
August 26, 2014
Fair Value ₹119
CMP ₹136
For detailed initiating coverage report please visit: www.ier.co.in
CRISIL Independent Equity Research reports are also available on Bloomberg (CRI <go>) and Thomson Reuters.
JBF Industries Ltd’s (JBF’s) Q1FY15 consolidated earnings were above CRISIL Research’s
expectations. Consolidated revenues remained flat y-o-y at ₹20.9 bn. EBITDA margin
expanded by 236 bps y-o-y to 9.9% driven by improvement in PET and POY spreads. JBF
reported adjusted PAT of ₹279 mn vs loss of ₹411 mn in Q1FY14 driven by higher EBITDA
margin and lower forex loss (₹49 mn in Q1FY15 vs ₹953 mn in Q1FY14). While PET and
POY spreads were healthy in Q1FY15, they have been declining over the past two months
due to an increase in PTA and MEG prices and also incremental supply (PET) in the global
markets. Also, films’ margins have remained subdued. Based on this, we remain cautious on
JBF’s ability to maintain its margins at the current level going forward. Also, increase in
offtake from the new plants – PET chips in Belgium and films in Bahrain – is a key
monitorable given the oversupply. We maintain the fundamental grade of 2/5.
Consolidated revenues remained flat y-o-y
Domestic revenues declined 2% y-o-y to ₹11.7 bn. PET chips sales increased 7% y-o-y to
₹6.1 bn (volumes up 7%, flat realisations). POY sales declined 11% y-o-y to ₹5.4 bn
(volumes down 14%, realisations up 4%). Scarce availability of PTA impacted POY
production and sales. Domestic sales are expected to remain flat y-o-y in FY15.
International revenues increased 2.3% y-o-y to ₹9.8 bn. PET chips sales declined 6% y-o-y
to ₹6.5 bn (volumes up 5%, realisation down 11% due to competitive pressure). Films sales
were up 27% y-o-y to ₹2.9 bn (volumes up 41%, realisations down 10% due to weak demand
and high competition). International sales are expected to post 27% growth in FY15 driven by
increase in sales from new capacities.
EBITDA margin improved by 236 bps y-o-y but may not be sustainable
Consolidated EBITDA margin improved by 236 bps y-o-y to 9.9% thanks to an improvement
in PET and POY spreads y-o-y driven by lower PTA and MEG prices. Domestic EBITDA
margin expanded by 170 bps y-o-y to 9.5% and overseas EBITDA margin was up 320 bps y-
o-y to 10.6%. However, global PTA prices have increased over the past two months. The
Indian government has also levied an anti-dumping duty on PTA imports, making the raw
material costlier by US$50-60 per tonne. As a result, spreads have declined over the past two
months – domestic PET spreads were down 30% in August over Q1FY15 and POY spreads
dipped 8%. We believe that the increase in raw material prices and supply are likely to weigh
on PET spreads for the rest of the year. Also, films spreads have been subdued due to weak
demand and oversupply in the industry. Hence, we forecast EBITDA margin of 8.2% in FY15.
FY15 earnings estimate raised; maintain fair value of ₹119
We have increased FY15 earnings estimate by 30% to factor in better-than-expected EBITDA
margin in Q1FY15. We maintain FY16 estimates and the discounted cash flow (DCF)-based
fair value of ₹119. At the current market price of ₹136, our valuation grade is 2/5.
KEY FORECAST
(₹ mn) FY12 FY13 FY14# FY15E FY16E
Operating income 71,772 74,551 85,677 96,949 109,363
EBITDA 7,141 6,957 7,120 7,989 11,595
Adj net income 1,948 968 237 822 977
Adj EPS (₹) 27.1 13.3 3.6 12.6 15.0
EPS growth (%) (64.2) (50.8) (72.8) 247.3 18.9
Dividend yield (%) 6.0 1.2 1.4 - -
RoCE (%) 13.9 9.2 6.6 5.2 6.6
RoE (%) 12.9 5.7 1.3 4.3 4.9
PE (x) 5.0 7.9 37.5 10.8 9.1
P/BV (x) 0.6 0.4 0.5 0.5 0.4
EV/EBITDA (x) 4.9 6.6 9.6 11.0 7.8
NM: Not meaningful; CMP: Current market price
# Based on abridged financials
Source: Company, CRISIL Research estimates
CFV MATRIX
KEY STOCK STATISTICS
NIFTY/SENSEX 7905/26443
NSE/BSE ticker JBFIND
Face value (₹ per share) 10
Shares outstanding (mn) 65.3
Market cap (₹ mn)/(US$ mn) 8,863/147
Enterprise value (₹ mn)/(US$ mn) 68,191/1,127
52-week range (₹)/(H/L) 151/64
Beta 1.2
Free float (%) 42.5%
Avg daily volumes (30-days) 110,155
Avg daily value (30-days) (₹ mn) 15.6
SHAREHOLDING PATTERN
PERFORMANCE VIS-À-VIS MARKET
Returns
1-m 3-m 6-m 12-m
JBF -2% 20% 105% 44%
CNX 500 2% 8% 31% 51%
ANALYTICAL CONTACT
Mohit Modi (Director) [email protected]
Kamna Motwani [email protected]
Bhaskar Bukrediwala [email protected]
Client servicing desk
+91 22 3342 3561 [email protected]
1 2 3 4 5
1
2
3
4
5
Valuation Grade
Fu
nd
am
en
tal G
rad
e
Poor
Fundamentals
Excellent
Fundamentals
Str
on
g
Do
wn
sid
e
Str
on
g
Up
sid
e55.9% 57.1% 57.1% 57.5%
11.2% 11.0% 11.0% 11.6%
9.9% 9.5% 6.5% 6.1%
22.9% 22.4% 25.5% 24.8%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Sep-13 Dec-13 Mar-14 Jun-14
Promoter FII DII Others
CRISIL IER Independent Equity Research
2
Q1FY15 results summary (Consolidated)
(₹ mn) Q1FY15 Q4FY14 Q1FY14 q-o-q (%) y-o-y (%)
Net sales 20,890 20,948 20,950 (0.3) (0.3)
Raw materials cost 15,584 16,063 16,621 (3.0) (6.2)
Raw materials cost (% of net sales) 74.6% 76.7% 79.3% -209bps -473bps
Employees cost 438 413 367 6.1 19.5
Other expenses 2,790 2,493 2,374 11.9 17.5
EBITDA 2,078 1,978 1,590 5.1 30.7
EBITDA margin 9.9% 9.4% 7.6% 51bps 236bps
Depreciation 649 678 540 (4.3) 20.1
EBIT 1,429 1,299 1,049 10.0 36.2
Finance cost (net) 898 921 643 (2.5) 39.7
Exchange difference and derivative (gain)/loss (net) 49 (129) 953 (137.8) (94.9)
Operating PBT 483 508 (546) (4.9) (188.4)
Extraordinary income/(expense) - 188 - - -
Other Income 7 (42) 47 (116.0) (86)
PBT 490 653 (499) (25.1) (198.1)
Tax 211 182 (89) NM (337.8)
PAT 279 472 (411) (40.9) (167.9)
Adj PAT 279 284 (411) (1.9) (167.9)
Adj PAT margin 1.3% 1.4% -2.0% -2bps 329bps
No of equity shares (mn) 65.3 65.3 72.7
(10.2)
Adj EPS (₹) 4.3 4.4 (5.6) (1.9) (175.6)
Source: Company, CRISIL Research
Geography-wise revenues
Q1FY15 Q4FY14 Q1FY14 q-o-q y-o-y
India 11,661 12,159 11,872 -4.1% -1.8%
International 9,580 9,183 9,365 4.3% 2.3%
Total 21,240 21,342 21,237 -0.5% 0.0%
Source: Company, CRISIL Research
EBITDA margin improved y-o-y due to better PET spreads PAT margin up y-o-y on higher EBITDA, lower forex loss
Source: Company, CRISIL Research Source: Company, CRISIL Research
18,1
08
17
,42
2
21
,04
7
20,9
50
22,4
44
21,3
36
20,9
48
20,8
90
9.5%10.2%
7.2%7.6%
9.2%
7.0%
9.4%9.9%
0%
2%
4%
6%
8%
10%
12%
-
5,000
10,000
15,000
20,000
25,000
Q2
FY
13
Q3
FY
13
Q4
FY
13
Q1
FY
14
Q2
FY
14
Q3
FY
14
Q4
FY
14
Q1
FY
15
(₹ mn)
Sales EBITDA Margin (RHS)
494 298 5
-411 -39
402
284 279
2.7%
1.7%
0.0%
-2.0%
-0.2%
0.2%
2.3%
1.3%
-4%
-3%
-2%
-1%
0%
1%
2%
3%
4%
-600
-400
-200
0
200
400
600
Q2
FY
13
Q3
FY
13
Q4
FY
13
Q1
FY
14
Q2
FY
14
Q3
FY
14
Q4
FY
14
Q1
FY
15
(₹ mn)
Adj PAT Adj PAT Margin (RHS)
JBF Industries Ltd
3
India: Prices flat y-o-y for both chips and POY Overseas: Films and chips prices under pressure
Source: Company, CRISIL Research Source: Company, CRISIL Research
India – volume trend Overseas – volume trend
Source: Company, CRISIL Research Source: Company, CRISIL Research
Domestic spreads trend Films spreads trend
Spreads = sale price – raw material cost
Source: Company, CRISIL Research Source: Company, CRISIL Research
80 83 89 8594 91 87 87 93 92 96 103 106 102 97
106
0
20
40
60
80
100
120
Q2
FY
13
Q3F
Y13
Q4F
Y13
Q1F
Y14
Q2F
Y14
Q3
FY
14
Q4F
Y14
Q1F
Y15
('000/MT)
India - Chips India - POY
1,4
00
1,5
00
1,6
00
1,5
00
1,5
00
1,6
00
1,2
50
1,3
00
2,3
00
2,2
00
2,3
00
2,3
00
2,4
00
2,2
50
2,2
00
2,1
00
0
500
1,000
1,500
2,000
2,500
Q2F
Y13
Q3F
Y13
Q4
FY
13
Q1
FY
14
Q2F
Y14
Q3F
Y14
Q4F
Y14
Q1F
Y15
(US$/MT)
UAE - Chips UAE Films
6455
7466 70
6169 71
54 57 5262
52 5258
53
0
10
20
30
40
50
60
70
80
Q2F
Y13
Q3F
Y13
Q4F
Y13
Q1F
Y14
Q2F
Y14
Q3F
Y14
Q4F
Y14
Q1F
Y15
('000 tonnes)
India - Chips India - POY
68 6574
84 83 87 84 89
18 19 20 17 17 18 20 24
0
10
20
30
40
50
60
70
80
90
100Q
2F
Y1
3
Q3F
Y13
Q4F
Y13
Q1F
Y14
Q2F
Y14
Q3
FY
14
Q4F
Y14
Q1F
Y15
('000 tonnes)
UAE - Chips UAE Films
8.2
6.0
6.1
5.7
8.1
7.0
7.4
8.2
21
.4
15
.0
13
.1
17
.7
19
.8
17
.5
18
.2
19
.3
0
5
10
15
20
25
Q2
FY
13
Q3
FY
13
Q4
FY
13
Q1
FY
14
Q2
FY
14
Q3
FY
14
Q4
FY
14
Q1
FY
15
(₹/kg)
Chips POY
950
750
950 900 850 800 800 800
0
100
200
300
400
500
600
700
800
900
1000
Q2
FY
13
Q3
FY
13
Q4
FY
13
Q1
FY
14
Q2
FY
14
Q3
FY
14
Q4
FY
14
Q1
FY
15
(US$/tonne)
Films
CRISIL IER Independent Equity Research
4
Share price movement Fair value movement since initiation
-Indexed to 100
Source: NSE, CRISIL Research Source: NSE, BSE, CRISIL Research
0
20
40
60
80
100
120
140
Ja
n-1
1
Ma
r-11
Ma
y-1
1
Au
g-1
1
Oc
t-1
1
Ja
n-1
2
Ma
r-12
Ma
y-1
2
Au
g-1
2
Oc
t-1
2
Ja
n-1
3
Ma
r-13
Ma
y-1
3
Au
g-1
3
Oc
t-1
3
Ja
n-1
4
Ma
r-14
Ma
y-1
4
Au
g-1
4
JBF CNX 500
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
0
50
100
150
200
250
300
No
v-0
9
Ma
r-1
0
Ju
l-10
Oct-
10
Ja
n-1
1
Ma
y-1
1
Au
g-1
1
De
c-1
1
Ma
r-1
2
Ju
l-12
Oct-
12
Fe
b-1
3
Ma
y-1
3
Se
p-1
3
Ja
n-1
4
Ap
r-14
Au
g-1
4
('000)(₹ )
Total Traded Quantity (RHS) CRISIL Fair Value JBF
JBF Industries Ltd
5
Earnings Estimates Revised Upwards
Particulars Unit
FY15E FY16E
Old New % change Old New % change
Revenues (₹ mn) 96,949 96,949 0.0% 109,363 109,363 0.0%
EBITDA (₹ mn) 7,796 7,989 2% 11,595 11,595 0%
EBITDA margin % 8.0 8.2 20bps 10.6 10.6 0bps
PAT (₹ mn) 629 822 30.7% 965 977 1.3%
PAT margin % 0.6 0.8 20bps 0.9 0.9 1bps
EPS ₹ 9.6 12.6 30.7% 14.8 15.0 1.3%
Source: CRISIL Research estimates
Reasons for changes in estimates
Line item FY15E FY16E
Revenues Maintained
EBITDA margins Increased due to better-than-expected EBITDA margin in
Q1FY15 Maintained
PAT margins Increased due to increase in EBITDA margin estimate Maintained
CRISIL IER Independent Equity Research
6
Valuation Grade: 2/5
The DCF-based fair value is maintained at ₹119 per share. This fair value implies P/E
multiples of 9.5x FY15E and 8.0x FY16E EPS. At the current market price of ₹136, the
valuation grade is 2/5.
One-year forward P/E band One-year forward EV/EBITDA band
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
P/E – premium / discount to CNX 500 P/E movement
Source: NSE, CRISIL Research Source: NSE, CRISIL Research
0
100
200
300
400
500
600
Ja
n-1
1
Ma
r-1
1
Ma
y-1
1
Ju
l-1
1
Oc
t-1
1
De
c-1
1
Fe
b-1
2
Ap
r-1
2
Ju
l-1
2
Se
p-1
2
No
v-1
2
Ja
n-1
3
Ap
r-1
3
Ju
n-1
3
Au
g-1
3
No
v-1
3
Ja
n-1
4
Ma
r-1
4
Ma
y-1
4
Au
g-1
4
(₹)
JBF 5x 7x 9x 11x 13x
0
10,000
20,000
30,000
40,000
50,000
60,000
Ja
n-1
1
Ma
r-11
Ma
y-1
1
Ju
l-1
1
Oc
t-1
1
De
c-1
1
Fe
b-1
2
Ap
r-1
2
Ju
l-1
2
Se
p-1
2
No
v-1
2
Ja
n-1
3
Ap
r-1
3
Ju
n-1
3
Au
g-1
3
No
v-1
3
Ja
n-1
4
Ma
r-14
Ma
y-1
4
Au
g-1
4
(₹ mn)
EV 3x 4x 5x 6x
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
Ja
n-1
1
Mar-
11
May
-11
Ju
l-1
1
Oc
t-1
1
Dec-1
1
Fe
b-1
2
May
-12
Jul-1
2
Se
p-1
2
Nov-1
2
Feb-1
3
Ap
r-1
3
Jun-1
3
Au
g-1
3
Nov-1
3
Jan-1
4
Ma
r-1
4
May
-14
Au
g-1
4
Premium/Discount to CNX 500
Median premium/discount to CNX 500
0
5
10
15
20
25
30
Jan-1
1
Mar-
11
May
-11
Jul-1
1
Oc
t-1
1
Dec
-11
Fe
b-1
2
Ap
r-1
2
Jul-1
2
Se
p-1
2
No
v-1
2
Jan-1
3
Ap
r-1
3
Jun-1
3
Au
g-1
3
Nov
-13
Jan-1
4
Mar-
14
May
-14
Au
g-1
4
(Times)
1yr Fwd PE (x) Median PE
+1 std dev
-1 std dev
Maintain fair value of ₹119
JBF Industries Ltd
7
CRISIL IER reports released on JBF Industries Ltd
Date Nature of report
Fundamental
grade Fair value
Valuation
grade
CMP
(on the date of report)
26-Nov-09 Initiating coverage 3/5 ₹119 4/5 ₹95
05-Feb-10 Q3FY10 result update 3/5 ₹129 4/5 ₹111
16-Jun-10 Q4FY10 result update 3/5 ₹154 3/5 ₹139
01-Sep-10 Q1FY11 result update 3/5 ₹203 5/5 ₹145
17-Nov-10 Q2FY11 result update 3/5 ₹232 4/5 ₹192
15-Mar-11 Q3FY11 result update 3/5 ₹259 5/5 ₹170
11-Jul-11 Detailed report 3/5 ₹229 5/5 ₹164
09-Aug-11 Q1FY12 result update 3/5 ₹229 5/5 ₹138
21-Nov-11 Q2FY12 result update 3/5 ₹194 5/5 ₹113
05-Mar-12 Q3FY12 result update 3/5 ₹194 5/5 ₹113
08-Jun-12 Q4FY12 result update 3/5 ₹194 5/5 ₹119
10-Jul-12 Detailed Report 3/5 ₹194 5/5 ₹135
14-Aug-12 Q1FY13 result update 3/5 ₹194 5/5 ₹136
19-Nov-12 Q2FY13 result update 3/5 ₹194 5/5 ₹128
20-Mar-13 Detailed report 2/5 ₹168 5/5 ₹102
13-June-13 Q4FY13 result update 2/5 ₹154 5/5 ₹102
17-Sept-13 Q1FY14 result update 2/5 ₹139 5/5 ₹98
12-Dec-13 Q2FY14 result update 2/5 ₹126 5/5 ₹76
13-Mar-14 Q3FY14 result update 2/5 ₹92 5/5 ₹68
08-Jul-14 Detailed report 2/5 ₹119 2/5 ₹145
26-Aug-14 Q1FY15 result update 2/5 ₹119 2/5 ₹136
CRISIL IER Independent Equity Research
8
Annexure: Financials (Consolidated)
# Based on abridged financials
Source: CRISIL Research
Income statement Balance Sheet
(₹ mn) FY12 FY13 FY14# FY15E FY16E (₹ mn) FY12 FY13 FY14# FY15E FY16E
Operating income 71,772 74,551 85,677 96,949 109,363 Liabilities
EBITDA 7,141 6,957 7,120 7,989 11,595 Equity share capital 720 726 653 653 653
EBITDA margin 10.0% 9.3% 8.3% 8.2% 10.6% Reserves 15,340 16,873 18,045 18,867 19,844
Depreciation 1,784 2,167 2,451 3,162 4,667 Minorities - - - - -
EBIT 5,357 4,790 4,669 4,828 6,928 Net worth 16,060 17,600 18,698 19,520 20,497
Interest 4,860 3,874 4,700 4,301 6,118 Convertible debt - - - - -
Operating PBT 497 916 (31) 527 810 Other debt 28,774 41,936 64,199 83,199 85,799
Other income 1,246 422 410 438 317 Total debt 28,774 41,936 64,199 83,199 85,799
Exceptional inc/(exp)* 281 167 (179) - - Deferred tax liability (net) 1,223 1,581 1,773 1,773 1,773
PBT 2,024 1,505 200 965 1,127 Total liabilities 46,058 61,116 84,670 104,492 108,069
Tax provision (205) 371 143 143 150 Assets
Minority interest - - - - - Net f ixed assets 27,607 32,141 37,939 50,269 84,843
PAT (Reported) 2,229 1,135 57 822 977 Capital WIP 3,814 10,597 29,433 37,024 2,086
Less: Exceptionals 281 167 (179) - - Total fixed assets 31,420 42,737 67,372 87,292 86,928
Adjusted PAT 1,948 968 237 822 977 Investments 1,877 3,762 33 33 33
Current assets
Ratios Inventory 7,918 9,231 10,440 11,953 13,183
FY12 FY13 FY14# FY15E FY16E Sundry debtors 7,617 10,803 11,507 12,404 13,937
Growth Loans and advances 3,900 5,554 6,558 7,756 8,749
Operating income (%) 11.0 3.9 14.9 13.2 12.8 Cash & bank balance 3,616 3,462 4,870 3,994 4,569
EBITDA (%) (25.8) (2.6) 2.3 12.2 45.1 Marketable securities - - - - -
Adj PAT (%) (64.0) (50.3) (75.5) 247.3 18.9 Total current assets 23,051 29,049 33,375 36,107 40,438
Adj EPS (%) (64.2) (50.8) (72.8) 247.3 18.9 Total current liabilities 11,314 15,537 17,157 19,987 20,377
Net current assets 11,737 13,512 16,217 16,119 20,060
Profitability Intangibles/Misc. expenditure 1,025 1,105 1,048 1,048 1,048
EBITDA margin (%) 10.0 9.3 8.3 8.2 10.6 Total assets 46,058 61,116 84,670 104,492 108,069
Adj PAT Margin (%) 2.7 1.3 0.3 0.8 0.9
RoE (%) 12.9 5.7 1.3 4.3 4.9 Cash flow
RoCE (%) 13.9 9.2 6.6 5.2 6.6 (₹ mn) FY12 FY13 FY14# FY15E FY16E
RoIC (%) 23.7 11.5 8.2 6.3 7.4 Pre-tax profit 1,744 1,338 379 965 1,127
Total tax paid (2) (13) 49 (143) (150)
Valuations Depreciation 1,784 2,167 2,451 3,162 4,667
Price-earnings (x) 5.0 7.9 37.5 10.8 9.1 Working capital changes (2,681) (1,929) (1,296) (778) (3,367)
Price-book (x) 0.6 0.4 0.5 0.5 0.4 Net cash from operations 845 1,563 1,583 3,205 2,277
EV/EBITDA (x) 4.9 6.6 9.6 11.0 7.8 Cash from investments
EV/Sales (x) 0.5 0.6 0.8 0.9 0.8 Capital expenditure (9,523) (13,564) (27,029) (23,081) (4,303)
Dividend payout ratio (%) 26.2 8.4 227.6 - - Investments and others (597) (1,886) 3,730 - -
Dividend yield (%) 6.0 1.2 1.5 - - Net cash from investments (10,121) (15,450) (23,300) (23,081) (4,303)
Cash from financing
B/S ratios Equity raised/(repaid) 36 60 (730) - -
Inventory days 46 52 49 49 49 Debt raised/(repaid) 10,672 13,161 22,263 19,000 2,600
Creditors days 57 80 74 77 71 Dividend (incl. tax) (678) (111) (153) - -
Debtor days 37 50 46 45 45 Others (incl extraordinaries) 511 623 1,745 - (0)
Working capital days 39 46 46 44 50 Net cash from financing 10,541 13,733 23,125 19,000 2,600
Gross asset turnover (x) 2.3 2.0 1.9 1.7 1.3 Change in cash position 1,265 (154) 1,409 (876) 574
Net asset turnover (x) 2.9 2.5 2.4 2.2 1.6 Closing cash 3,616 3,462 4,870 3,994 4,569
Sales/operating assets (x) 2.6 2.0 1.6 1.3 1.3
Current ratio (x) 2.0 1.9 1.9 1.8 2.0
Debt-equity (x) 1.8 2.4 3.4 4.3 4.2 Quarterly financials
Net debt/equity (x) 1.6 2.2 3.2 4.1 4.0 (₹ mn) Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15
EBITDA/Interest (x) 1.5 1.8 1.5 1.9 1.9 Net Sales 20,950 22,444 21,336 20,948 20,890
EBIT/Interest (x) 1.1 1.2 1.0 1.1 1.1 Change (q-o-q) 0% 7% -5% -2% 0%
EBITDA 1,590 2,055 1,497 1,978 2,078
Per share Change (q-o-q) 5% 29% -27% 32% 5%
FY12 FY13 FY14# FY15E FY16E EBITDA margin 8% 9% 7% 9% 10%
Adj EPS (₹ ) 27.1 13.3 3.6 12.6 15.0 PAT (411) (39) 35 472 279
CEPS 51.8 43.2 41.1 61.0 86.4 Adj PAT (411) (39) 402 284 279
Book value 223.0 242.3 286.3 298.8 313.8 Change (q-o-q) NM NM NM -29% -2%
Dividend (₹ ) 8.1 1.3 2.0 - - Adj PAT margin -2% 0% 2% 1% 1.3%
Actual o/s shares (mn) 72.0 72.6 65.3 65.3 65.3 Adj EPS (5.7) (0.6) 6.2 4.4 4.3
This page is intentionally left blank
CRISIL IER Independent Equity Research
CRISIL Research Team
President
Mukesh Agarwal CRISIL Research +91 22 3342 3035 [email protected]
Analytical Contacts
Sandeep Sabharwal Senior Director, Capital Markets +91 22 4097 8052 [email protected]
Prasad Koparkar Senior Director, Industry & Customised Research +91 22 3342 3137 [email protected]
Binaifer Jehani Director, Customised Research +91 22 3342 4091 [email protected]
Manoj Mohta Director, Customised Research +91 22 3342 3554 [email protected]
Sudhir Nair Director, Customised Research +91 22 3342 3526 [email protected]
Mohit Modi Director, Equity Research +91 22 4254 2860 [email protected]
Jiju Vidyadharan Director, Funds & Fixed Income Research +91 22 3342 8091 [email protected]
Ajay D'Souza Director, Industry Research +91 22 3342 3567 [email protected]
Ajay Srinivasan Director, Industry Research +91 22 3342 3530 [email protected]
Rahul Prithiani Director, Industry Research +91 22 3342 3574 [email protected]
Business Development
Hani Jalan Director, Capital Markets +91 22 3342 3077 [email protected]
Prosenjit Ghosh Director, Industry & Customised Research +91 22 3342 8008 [email protected]
Business Development – Equity Research
Vikram Thirani – Associate Director
Email : [email protected]
Phone : +91 9820199188
Saurabh Sabharwal – Business Development Manager
Email : [email protected]
Phone : +91 9650228684
Priyanka Murarka – Regional Manager
Email : [email protected]
Phone : +91 9903060685
Our Capabilities
Making Markets Function Better
Economy and Industry Research
▪ Largest team of economy and industry research analysts in India
▪ Coverage on 70 industries and 139 sub-sectors; provide growth forecasts, profitability analysis, emerging trends,
expected investments, industry structure and regulatory frameworks
▪ 90 per cent of India’s commercial banks use our industry research for credit decisions
▪ Special coverage on key growth sectors including real estate, infrastructure, logistics, and financial services
▪ Inputs to India’s leading corporates in market sizing, demand forecasting, and project feasibility
▪ Published the first India-focused report on Ultra High Net-worth Individuals
▪ All opinions and forecasts reviewed by a highly qualified panel with over 200 years of cumulative experience
Funds and Fixed Income Research
▪ Largest and most comprehensive database on India’s debt market, covering more than 15,000 securities
▪ Largest provider of fixed income valuations in India
▪ Value more than ₹53 trillion (US$ 960 billion) of Indian debt securities, comprising outstanding securities
▪ Sole provider of fixed income and hybrid indices to mutual funds and insurance companies; we maintain 12
standard indices and over 100 customised indices
▪ Ranking of Indian mutual fund schemes covering 70 per cent of assets under management and ₹4.7 trillion
(US$ 85 billion) by value
▪ Retained by India’s Employees’ Provident Fund Organisation, the world’s largest retirement scheme covering
over 60 million individuals, for selecting fund managers and monitoring their performance
Equity and Company Research
▪ Largest independent equity research house in India, focusing on small and mid-cap companies; coverage
exceeds 125 companies
▪ Released company reports on 1,442 companies listed and traded on the National Stock Exchange; a global first
for any stock exchange
▪ First research house to release exchange-commissioned equity research reports in India
▪ Assigned the first IPO grade in India
Our Office
Ahmedabad
706, Venus Atlantis
Nr. Reliance Petrol Pump
Prahladnagar, Ahmedabad, India
Phone: +91 79 4024 4500
Fax: +91 79 2755 9863
Hyderabad
3rd Floor, Uma Chambers
Plot No. 9&10, Nagarjuna Hills,
(Near Punjagutta Cross Road)
Hyderabad - 500 482, India
Phone: +91 40 2335 8103/05
Fax: +91 40 2335 7507
Bengaluru
W-101, Sunrise Chambers,
22, Ulsoor Road,
Bengaluru - 560 042, India
Phone: +91 80 2558 0899
+91 80 2559 4802
Fax: +91 80 2559 4801
Kolkata
Horizon, Block 'B', 4th Floor
57 Chowringhee Road
Kolkata - 700 071, India
Phone: +91 33 2289 1949/50
Fax: +91 33 2283 0597
Chennai
Thapar House,
43/44, Montieth Road, Egmore,
Chennai - 600 008, India
Phone: +91 44 2854 6205/06
+91 44 2854 6093
Fax: +91 44 2854 7531
Pune
1187/17, Ghole Road,
Shivaji Nagar,
Pune - 411 005, India
Phone: +91 20 2553 9064/67
Fax: +91 20 4018 1930
Gurgaon
Plot No. 46
Sector 44
Opp. PF Office
Gurgaon - 122 003, India
Phone: +91 124 6722 000
Stay Connected | CRISIL Website |
Twitter |
LinkedIn |
YouTube |
CRISIL Ltd is a Standard & Poor's company
CRISIL Limited
CRISIL House, Central Avenue,
Hiranandani Business Park, Powai, Mumbai – 400076. India
Phone: +91 22 3342 3000 | Fax: +91 22 3342 8088
www.crisil.com